While some individuals may experience candidiasis once or twice in their lifetime, others face recurring infections. Candidiasis, commonly referred to as a yeast infection, is a fungal infection ...

Please provide your email address to receive an email when new articles are posted on . Oteseconazole, an investigational oral antifungal therapy, was shown to be safe and effective in the treatment ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved ibrexafungerp, an oral, non-azole antifungal drug, for reducing the number of recurrent ...

Vivjoa is a novel oral inhibitor of fungal CYP51. Vivjoa ™ (oteseconazole) is now available to reduce the incidence of recurrent vulvovaginal candidiasis (RVVC) in females with a history of RVVC who ...

Credit: Getty Images. The approval was based on data from three phase 3 trials, which included female patients aged 12 years and older with at least 3 episodes of acute VVC in the past 12 months. The ...

The drug, oteseconazole, is an azole antifungal indicated to reduce the incidence of recurrent vulvovaginal candidiasis in females who are infertile or postmenopausal. The FDA recently approved the ...

A phase 3 randomized, double-blind, controlled trial has shown that oteseconazole (Mycovia Pharmaceuticals), an oral antifungal agent, is safe and effective in treating acute and recurrent yeast ...

Thrush is one of the most common infections in the world. It's caused by the fungi Candida—specifically, the yeast Candida albicans. Although yeast infections are normally treated easily with ...

After years of recurrent infections and misdiagnosis, Philly Baines spent £80,000 searching for relief ...

Candidiasis, commonly referred to as a yeast infection, is a fungal infection caused by the overgrowth of Candida species of fungus, which naturally resides in various parts of our body, including the ...

Before becoming seriously unwell at the age of 32, Philly Baines, now 35, says she was lucky enough to have never experienced any health problems. With a successful copywriting career and an upcoming ...